Angelika Brekman

411 total citations
10 papers, 316 citations indexed

About

Angelika Brekman is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Angelika Brekman has authored 10 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Angelika Brekman's work include Cancer-related Molecular Pathways (6 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Angelika Brekman is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Angelika Brekman collaborates with scholars based in United States and China. Angelika Brekman's co-authors include Ronald G. Crystal, Jill Bargonetti, Matthew S. Walters, Ann E. Tilley, Nandini Kundu, Alla Polotskaia, Kathryn Singh, Renat Shaykhiev, Tomoya Fukui and Wu‐Lin Zuo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Cancer Research.

In The Last Decade

Angelika Brekman

10 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelika Brekman United States 7 153 125 108 43 30 10 316
Heladio P. Ibarguen United States 8 132 0.9× 63 0.5× 117 1.1× 45 1.0× 45 1.5× 10 310
Ignacio Fernandez‐Garcia United States 7 158 1.0× 52 0.4× 115 1.1× 71 1.7× 22 0.7× 8 297
Vinay Raj United States 10 134 0.9× 50 0.4× 50 0.5× 96 2.2× 23 0.8× 17 294
Guolian Zhu China 12 181 1.2× 201 1.6× 122 1.1× 104 2.4× 33 1.1× 23 521
Surya Amarachintha United States 13 191 1.2× 36 0.3× 59 0.5× 43 1.0× 30 1.0× 26 358
Zhong-ze Li United States 7 126 0.8× 95 0.8× 109 1.0× 35 0.8× 65 2.2× 8 361
Linglong Peng China 11 124 0.8× 43 0.3× 58 0.5× 71 1.7× 26 0.9× 33 288
Jessica Vick United States 6 187 1.2× 121 1.0× 69 0.6× 147 3.4× 8 0.3× 7 323

Countries citing papers authored by Angelika Brekman

Since Specialization
Citations

This map shows the geographic impact of Angelika Brekman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelika Brekman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelika Brekman more than expected).

Fields of papers citing papers by Angelika Brekman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelika Brekman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelika Brekman. The network helps show where Angelika Brekman may publish in the future.

Co-authorship network of co-authors of Angelika Brekman

This figure shows the co-authorship network connecting the top 25 collaborators of Angelika Brekman. A scholar is included among the top collaborators of Angelika Brekman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelika Brekman. Angelika Brekman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kundu, Nandini, et al.. (2017). Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway. Oncotarget. 8(29). 47916–47930. 24 indexed citations
2.
Brekman, Angelika, Xuemei Ou, Renat Shaykhiev, et al.. (2016). POU2AF1 Functions in the Human Airway Epithelium To Regulate Expression of Host Defense Genes. The Journal of Immunology. 196(7). 3159–3167. 36 indexed citations
3.
Brekman, Angelika, Matthew S. Walters, Ann E. Tilley, & Ronald G. Crystal. (2014). FOXJ1 Prevents Cilia Growth Inhibition by Cigarette Smoke in Human Airway Epithelium In Vitro. American Journal of Respiratory Cell and Molecular Biology. 51(5). 688–700. 71 indexed citations
4.
Shaykhiev, Renat, et al.. (2013). EGF shifts human airway basal cell fate toward a smoking-associated airway epithelial phenotype. Proceedings of the National Academy of Sciences. 110(29). 12102–12107. 71 indexed citations
5.
Bargonetti, Jill, et al.. (2012). Abstract 1169: Non-canonical functions of Mdm2 isoforms in estrogen influenced breast cancer cells with wild-type or mutant p53. Cancer Research. 72(8_Supplement). 1169–1169. 1 indexed citations
6.
Brekman, Angelika, Kathryn Singh, Alla Polotskaia, Nandini Kundu, & Jill Bargonetti. (2011). A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation. Breast Cancer Research. 13(1). R3–R3. 69 indexed citations
7.
Brekman, Angelika, Maria Tomasz, Natura Myeku, et al.. (2010). DNA Adducts of Decarbamoyl Mitomycin C Efficiently Kill Cells without Wild-Type p53 Resulting from Proteasome-Mediated Degradation of Checkpoint Protein 1. Chemical Research in Toxicology. 23(7). 1151–1162. 18 indexed citations
8.
Brekman, Angelika, et al.. (2009). p53 transcriptional activity is selectively suppressed by estrogen in SNP309 mdm2 overexpressing breast cancer cells.. Cancer Research. 69(2_Supplement). 4065–4065. 1 indexed citations
9.
Arva, Nicoleta C., et al.. (2008). Disruption of the p53-Mdm2 complex by Nutlin-3 reveals different cancer cell phenotypes.. PubMed. 18(2 Suppl 2). S2–1. 20 indexed citations
10.
Kawamura, Akira, et al.. (2006). Rediscovery of natural products using genomic tools. Bioorganic & Medicinal Chemistry Letters. 16(11). 2846–2849. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026